mTOR Inhibitors as a New Therapeutic Strategy in Treatment Resistant Epilepsy in Hemimegalencephaly: A Case Report.

J Child Neurol 2019 03 5;34(3):132-138. Epub 2018 Dec 5.

1 Division of Neurology, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.

Hemimegalencephaly is a hamartomatous malformation of one hemisphere. Functional hemispherectomy, the definitive treatment, is associated with significant morbidity and mortality in early infancy. Dysregulation of the mTOR pathway can result in malformations of cortical development, and mTOR inhibitors can effectively reduce seizures in tuberous sclerosis complex. We report a 6-day-old female with hemimegalencephaly and frequent seizures despite 9 antiseizure medications. At 3 months of age, while awaiting hemispherectomy, an mTOR inhibitor, rapamycin, was initiated by the neurologist. After 1 week of treatment, there was >50% reduction in seizures and total seizure burden, and after 2 weeks, development improved, resulting in deferral of surgery by 2.5 months with an increased body weight. Pathology demonstrated cortical dysplasia with upregulation of the mTOR pathway. Deep-sequencing of brain tissue demonstrated 16% mosaicism for a pathogenic de novo MTOR gene mutation. This case exemplifies how mTOR inhibitors could be considered for seizure reduction in patients with hemimegalencephaly while awaiting surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0883073818813238DOI Listing
March 2019
19 Reads

Publication Analysis

Top Keywords

mtor inhibitors
12
mtor pathway
8
mtor
7
despite antiseizure
4
brain tissue
4
mtor inhibitor
4
tissue demonstrated
4
seizures despite
4
antiseizure medications
4
medications months
4
awaiting hemispherectomy
4
age awaiting
4
months age
4
frequent seizures
4
hemispherectomy mtor
4
demonstrated 16%
4
mosaicism pathogenic
4
tuberous sclerosis
4
reduce seizures
4
effectively reduce
4

Similar Publications